VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Pharma Milestone: UCB's Bimzelx Hits Phase 3 Endpoint in Psoriatic Arthritis; Pfizer's 25-Valent Pneumococcal Vaccine Shows Strong Phase 2 Results
Pharma Milestone: UCB's Bimzelx Hits Phase 3 Endpoint in Psoriatic Arthritis; Pfizer's 25-Valent Pneumococcal Vaccine Shows Strong Phase 2 Results
May 21, 2026 07:30 CST Updated 10:23
Share:
